Skip to content
Open access · CC-BY via OpenAlex

Targeting MAPK Signaling in Age-Related Macular Degeneration

Svetlana V. Kyosseva

Ophthalmology and Eye Diseases · 2016 · ▲ 75 citations

Abstract

Age-related macular degeneration (AMD) is a major cause of irreversible blindness affecting elderly people in the world. AMD is a complex multifactorial disease associated with demographic, genetics, and environmental risk factors. It is well established that oxidative stress, inflammation, and apoptosis play critical roles in the pathogenesis of AMD. The mitogen-activated protein kinase (MAPK) signaling pathways are activated by diverse extracellular stimuli, including growth factors, mitogens, hormones, cytokines, and different cellular stressors such as oxidative stress. They regulate cell proliferation, differentiation, survival, and apoptosis. This review addresses the novel findings from human and animal studies on the relationship of MAPK signaling with AMD. The use of specific MAPK inhibitors may represent a potential therapeutic target for the treatment of this debilitating eye disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4137/oed.s32200
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Kyosseva, S.V. (2016). Targeting MAPK Signaling in Age-Related Macular Degeneration. <em>Ophthalmology and Eye Diseases</em>. https://doi.org/10.4137/oed.s32200
Vancouver
Kyosseva SV. Targeting MAPK Signaling in Age-Related Macular Degeneration. Ophthalmology and Eye Diseases. 2016. doi:10.4137/oed.s32200.
BibTeX
@article{svetlana2016Target, title = {Targeting MAPK Signaling in Age-Related Macular Degeneration}, author = {Svetlana V. Kyosseva}, journal = {Ophthalmology and Eye Diseases}, year = {2016}, doi = {10.4137/oed.s32200}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings